Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |